ClinicalTrials.govpublic full text
MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin
hepatic steato-fibrosis, non-alcoholic fatty liver disease, dapaglifozin, mri-pdff, primary hypothyroidism, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 906707
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.